Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
All participants with detectable HIV on oral meds achieved viral suppression after switching to long-acting injectables.
Despite progress in some areas, more work is needed to improve health and quality of life.
Drug levels remained adequate throughout pregnancy, so no dose adjustment was needed.
Global study highlights the importance of prompt HIV treatment and viral suppression to prevent severe monkeypox.
44% of children treated with two bnAbs maintained viral suppression after stopping antiretrovirals.
Once-daily Biktarvy, long-acting injectable Cabenuva and two-drug combos containing dolutegravir can keep HIV in check for years.
Gene therapy that alters CCR5 receptors and excises HIV from infected cells eliminated the virus in mice.
The risk of mother-to-child HIV transmission fell below 1% for the first time in 2019.
Starting HIV treatment later and having a lower CD4 count were also linked to serious non-AIDS events.
People with suppressed HIV respond well to mRNA vaccines, but individuals with a low CD4 count may not be adequately protected.
Given the current standard of care, life expectancy for Black men who have sex with men is 6.3 years shorter than that of their white peers.
For the first time, gay and bi men who don’t inject drugs accounted for less than half of new cases in San Francisco.
People on opioid substitution therapy were more likely to adhere to antiretroviral treatment and achieve viral suppression.
People with well-controlled HIV don’t have more severe illness, but HIV-positive people might not respond as well to monkeypox vaccines.
A new case may provide clues to help researchers develop strategies for a functional cure.
COVID-19 had an “immense impact” on HIV, hepatitis and STI screening, prevention and care.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.